Biodefense Market by Technology (GHz-band Wave, Microwave Heating, RF-EMR, Cold Plasma, Gamma, UV), Product (Decontamination (Sterilization Devices, Disinfection Units), Biosensors, AI Surveillance), Application, Region - Global Forecast to 2030
세계의 바이오디펜스 시장 규모는 2025년에 8억 9,000만 달러로 추정되며, 예측 기간 동안 CAGR 15.1% 성장하여 2030년까지 18억 1,000만 달러에 달할 것으로 예상됩니다.
기술의 발전과 시장 환경의 변화는 바이오디펜스 시장의 주요 촉진요인입니다.
| 조사 범위 |
| 조사 대상 연도 |
2020-2030년 |
| 기준 연도 |
2024년 |
| 예측 기간 |
2025-2030년 |
| 단위 |
10억 달러 |
| 부문 |
기술, 제품, 용도, 지역 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 기타 지역 |
"제품별로는 제균 멸균기가 2025년 가장 큰 시장 점유율을 차지할 것으로 추정됩니다."
제품을 기준으로 오염 제거는 소독 장비와 살균기로 분류됩니다. 살균기는 의료, 국방 및 실험실 환경에서 광범위한 생물학적 병원균을 제거하는 데 필수적인 기능이기 때문에 2025년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 저온 살균기, 과산화수소 증기 시스템, 마이크로파 살균기, 감마선 조사 솔루션에 대한 수요가 증가함에 따라 의료기기, 실험실 표면 및 섬세한 장비를 오염 제거하기 위한 안정적이고 효과적인 방법을 찾는 조직에 대한 요구가 증가하고 있습니다. 이러한 장비는 고성능, 규제 승인, 복잡하고 열에 민감한 재료와의 호환성을 제공하며 병원, 연구 시설 및 이동식 생물학적 격리 장비의 생물학적 안전 규제에 필수적입니다.
"기술별로는 바이오센서 기반 기술 부문이 2025년 가장 큰 시장 점유율을 차지할 것으로 추정됩니다."
기술별로는 바이오센서 기반 기술이 생물학적 위협에 대한 실시간, 정확한 분산형 센싱을 제공하는 매우 중요한 기능으로 인해 2025년까지 바이오디펜스 시장에서 가장 큰 시장 규모를 차지할 것으로 추정됩니다. 바이오센서 기반 기술은 탄저균, 리신, 신종 바이러스와 같은 병원균을 감지하는 민감하고 빠른 반응으로 병원, 국방군, 국경관리, 공중보건기관 등에서 널리 사용되고 있습니다. POC(Point-of-Care) 진단의 등장과 바이오 디펜스 애플리케이션의 조기 경보 시스템에 대한 수요 증가는 바이오센서 기술의 활용을 크게 촉진하고 있습니다. 군대 야전에서부터 도시 병원 및 이동식 실험실까지 다양한 환경에서의 범용성은 바이오센서 기술을 바이오디펜스 시장에서 가치 있게 만들고 있습니다.
"유럽이 2025년 시장 점유율 2위를 차지할 것으로 추정됩니다."
유럽은 바이오 보안 및 팬데믹 대비를 강화하기 위한 정부의 노력이 확대됨에 따라 바이오방어 시장에서 두 번째로 큰 점유율을 차지할 것으로 추정됩니다. 이 지역에서는 생물 감시 인프라와 오염 제거 기술에 대한 투자가 증가하고 있습니다. 독일, 프랑스, 영국과 같은 국가들은 강력한 공중보건 시스템과 국가 차원의 생물방어 전략으로 최전선에 서 있습니다.
또한, 방위기관, 생명공학 기업, 연구기관 간의 강력한 파트너십은 이동식 생물학적 봉쇄 장치, 바이오센서, AI 기반 위협 감지 등 기술 혁신을 촉진하고 있으며, Horizon Europe과 같은 EU 차원의 지원과 European Centre for Disease Prevention and Control(ECDC)과의 협력은 지역적 대응력을 더욱 향상시키고 있습니다.
세계의 바이오디펜스 시장에 대해 조사 분석했으며, 주요 촉진요인과 억제요인, 경쟁 상황, 향후 동향 등의 정보를 전해드립니다.
목차
제1장 소개
제2장 조사 방법
제3장 주요 요약
제4장 주요 조사 결과
- 바이오디펜스 시장 기업에서 매력적인 기회
- 바이오디펜스 시장 : 제품별
- 바이오디펜스 시장 : 기술별
- 바이오디펜스 시장 : 용도별
- 바이오디펜스 시장 : 국가별
제5장 시장 개요
- 소개
- 시장 역학
- 고객의 비즈니스에 영향을 미치는 동향과 혼란
- 밸류체인 분석
- 연구개발(약 10-20%)
- 원재료 제조업체(약 20-40%)
- 제품 제조(약 40-60%)
- 테스트·품질 보증(약 60-80%)
- 최종사용자(약 80-100%)
- 생태계 분석
- 관세와 규제 상황
- 무역 데이터
- 주요 이해관계자와 구입 기준
- 이용 사례 분석
- 주요 회의와 이벤트(2025-2026년)
- 가격 분석
- 바이오디펜스 제품 평균판매가격 : 지역별
- 바이오디펜스 시장의 비용에 영향을 미치는 요인
- 바이오디펜스 기술 참고 가격 분석 : 주요 기업별(2025년)
- 투자와 자금 조달 시나리오
- 바이오디펜스 시장에 대한 AI/생성형 AI의 영향
- 예측적 바이오서베일런스
- 차세대 바이오센서
- 신속한 병원체 동정
- 영상·신호 해석
- 합성 데이터 생성
- 거시경제 전망
- 소개
- 북미
- 유럽
- 아시아태평양
- 중동
- 라틴아메리카
- 아프리카
- 비즈니스 모델
- 기술 로드맵
제6장 산업 동향
- 소개
- 기술 동향
- 나노기술을 활용한 바이오센서
- 디지털 헬스 툴과 모바일 바이오서베일런스
- 생물학적 위협 탐지와 식별에 이용하는 원격탐사
- 디지털 트윈·시뮬레이션 기술
- 메가트렌드의 영향
- 생물학적 위협 검출에 이용하는 AI와 머신러닝
- 공급망과 데이터 무결성에 이용하는 블록체인
- 기술 분석
- 특허 분석
제7장 바이오디펜스 시장 : 제품별
제8장 바이오디펜스 시장 : 기술별
- 소개
- GHz대 전파 방사에 의한 공기 감염 바이러스 비활성화
- UV 기반 기술
- 마이크로파 가열
- 고주파(RF-EMR) 가열
- 저온 플라즈마 기반 병원체 비활성화
- 감마선
- 바이오센서 기술
- AI 기술
- 기타
제9장 바이오디펜스 시장 : 용도별
- 소개
- 군사
- 국토안보
- 공공 인프라
- 병원·의료기관
- 기타
제10장 바이오디펜스 시장 : 지역별
- 소개
- 북미
- 아시아태평양
- PESTLE 분석
- 인도
- 호주
- 중국
- 일본
- 기타 아시아태평양
- 유럽
- PESTLE 분석
- 독일
- 영국
- 프랑스
- 이탈리아
- 기타 유럽
- 기타 지역
- PESTLE 분석
- 중동 및 아프리카
- 라틴아메리카
제11장 경쟁 구도
- 소개
- 주요 진출 기업 전략/강점(2020-2025년)
- 바이오디펜스 시장 매출 분석(2020-2025년)
- 바이오디펜스 시장 점유율 분석(2024년)
- 바이오디펜스 시장 기업 평가 매트릭스 : 주요 기업(2024년)
- 바이오디펜스 시장 기업 평가 매트릭스 : 스타트업/중소기업(2024년)
- 브랜드/제품의 비교
- 기업 평가와 재무 지표
- 경쟁 시나리오
제12장 기업 개요
- 주요 기업
- STERIS
- ASP INTERNATIONAL GMBH
- USHIO INC.
- SOTERA HEALTH COMPANY
- BIOQUELL, AN ECOLAB SOLUTION
- THERMO FISHER SCIENTIFIC INC.
- SMITHS DETECTION GROUP LTD
- E4LIFE SRL.
- SYNEXIS
- BLUEDOT INC.
- XENEX DISINFECTION SERVICES INC.
- SKAN AG
- MICROSOFT
- BIO-RAD LABORATORIES, INC.
- AIRBOSS DEFENSE GROUP, INC.
- 기타 기업
- IONISOS
- AQUISENSE
- GERMFREE
- PATHOGENFOCUS
- UV LIGHT TECHNOLOGY LTD-PART OF DARO GROUP
- BERTIN TECHNOLOGIES
- FAR UV TECHNOLOGIES, INC.
- PURE AQUA, INC.
- PALANTIR TECHNOLOGIES INC.
- PUSCHNER MICROWAVE POWER SYSTEMS
제13장 부록
ksm
The biodefense market is estimated at USD 0.89 billion in 2025 and is projected to reach USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period. Technological advancements and changing market conditions are the key drivers of the biodefense market.
| Scope of the Report |
|---|
| Years Considered for the Study | 2020-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Billion) |
| Segments | By Technology, Product, Application and Region |
| Regions covered | North America, Europe, APAC, RoW |
"Based on product, sterilization devices under decontamination is estimated to hold the largest market share in 2025."
Based on product, decontamination is categorized into disinfection units and sterilization devices. Sterilization devices are expected to account for the largest market share in 2025 due to their indispensable function in eliminating a broad biological agent in healthcare, defense, and laboratory environments. The growing need for low-temperature sterilizers, hydrogen peroxide vapor systems, microwave sterilizer units, and gamma irradiation solutions has increased the need for organizations to find stable, validated procedures for decontaminating medical equipment, laboratory surfaces, and delicate equipment. These instruments provide high performance, regulatory approval, and compatibility with intricate and heat-sensitive materials, which are critical to biosafety regulations in hospitals, research facilities, and mobile bio-containment units.
"Biosensor-based technologies segment is estimated to hold the largest market share in 2025 by technology."
Based on technology, biosensor-based technologies are estimated to account for the largest market in the biodefense market by 2025 due to their pivotal function in providing real-time, precise, and decentralized sensing of biological threats. Biosensor-based technologies are being widely used in hospitals, defense forces, border control, and public health organizations for their high sensitivity and quick response to detecting pathogens like anthrax, ricin, and new viruses. The emergence of point-of-care diagnostics and increasing demand for early warning systems in biodefense applications have considerably enhanced the usage of biosensor technologies. Their versatility in varied environments, ranging from military field operations to urban hospitals and mobile laboratories, makes them valuable to the biodefense market.
"Europe is estimated to hold the second-largest market share in 2025."
Europe is estimated to have the second-largest share of the biodefense market due to growing government efforts to enhance biosecurity and pandemic preparedness. The region has witnessed increased investment in biosurveillance infrastructure and decontamination technologies. Countries such as Germany, France, and the UK are at the forefront with strong public health systems and country-level biodefense strategies.
Besides that, robust partnerships among defense agencies, biotech firms, and research organizations have boosted innovation in technologies like mobile biocontainment units, biosensors, and AI-based threat detection. Support from EU-wide initiatives such as Horizon Europe and cooperation with the European Centre for Disease Prevention and Control (ECDC) further boost regional readiness.
The break-up of the profile of primary participants in the biodefense market:
- By Company Type: Tier 1 - 35%, Tier 2 - 54%, and Tier 3 - 20%
- By Designation: Directors- 55%, Managers - 27%, Others - 18%
- By Region: North America - 40%, Europe - 20%, Asia Pacific - 30%, Rest of the World - 10%
STERIS (US), ASP International GmbH (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK) are the key market players that offer connectivity applicable to various sectors and have well-equipped and strong distribution networks across North America, Europe, Asia Pacific, and the Rest of the World.
Research Coverage:
The study covers the biodefense market across various segments and subsegments. It aims to estimate the size and growth potential of this market across different segments based on product, application, technology, and region. This study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their solutions and business offerings, recent developments undertaken by them, and key market strategies adopted by them.
This report segments the biodefense market across five key regions: North America, Europe, Asia Pacific, and the Rest of the World and their respective key countries. The report's scope includes in-depth information on significant factors, such as drivers, restraints, challenges, and opportunities that influence the growth of the biodefense market.
A comprehensive analysis of major industry players has been conducted to provide insights into their business profiles, solutions, and services. This analysis also covers key aspects like agreements, collaborations, product launches, contracts, expansions, acquisitions, and partnerships associated with the biodefense market.
Reasons to buy this report:
This report serves as a valuable resource for market leaders and newcomers in the biodefense market, offering data that closely approximates revenue figures for both the overall market and its subsegments. It equips stakeholders with a comprehensive understanding of the competitive landscape, facilitating informed decisions to enhance their market positioning and formulating effective go-to-market strategies. The report imparts valuable insights into the market dynamics, offering information on crucial factors such as drivers, restraints, challenges, and opportunities, enabling stakeholders to gauge the market's pulse.
The report provides insights into the following pointers:
- Analysis of Key Drivers: Rising threat of bioterrorism, high government funding, strategic national stockpiling, and increasing technological advancements
- Market Penetration: Comprehensive information on biodefense solutions offered by the top players in the market
- Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the biodefense market
- Market Development: Comprehensive information about lucrative markets; the report analyses the biodefense market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the biodefense market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players in the biodefense market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 BIODEFENSE MARKET SEGMENTATION
- 1.3.2 YEARS CONSIDERED
- 1.4 CURRENCY AND PRICING
- 1.5 INCLUSIONS AND EXCLUSIONS
- 1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Key primary sources
- 2.1.2.2 Key data from primary sources
- 2.1.2.3 Breakdown of primary interviews
- 2.2 FACTOR ANALYSIS
- 2.2.1 INTRODUCTION
- 2.2.2 DEMAND-SIDE INDICATORS
- 2.2.3 SUPPLY-SIDE INDICATORS
- 2.3 MARKET SIZE ESTIMATION
- 2.3.1 BOTTOM-UP APPROACH
- 2.3.1.1 Company revenue estimation approach
- 2.3.1.2 Growth rate projections
- 2.3.2 TOP-DOWN APPROACH
- 2.3.2.1 Market assessment by region and country
- 2.4 DATA TRIANGULATION
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 RISK ANALYSIS
- 2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BIODEFENSE MARKET
- 4.2 BIODEFENSE MARKET, BY PRODUCT
- 4.3 BIODEFENSE MARKET, BY TECHNOLOGY
- 4.4 BIODEFENSE MARKET, BY APPLICATION
- 4.5 BIODEFENSE MARKET, BY COUNTRY
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Rising threat of bioterrorism
- 5.2.1.2 Increase in government funding and strategic national stockpiling
- 5.2.1.3 Technological advancements and innovations
- 5.2.1.4 Growing geopolitical tensions and biological warfare risks
- 5.2.2 RESTRAINTS
- 5.2.2.1 High R&D costs and long approval times
- 5.2.2.2 Lack of global standardization in biodefense protocols
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Emergence of AI-powered biosurveillance & predictive analytics
- 5.2.3.2 Emergence of nanotechnology-based biosensors
- 5.2.4 CHALLENGES
- 5.2.4.1 Infrastructure shortages in low-resource areas
- 5.2.4.2 Cybersecurity risks in connected biodefense systems
- 5.3 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.4 VALUE CHAIN ANALYSIS
- 5.4.1 RESEARCH & DEVELOPMENT (~10-20%)
- 5.4.2 RAW MATERIAL PRODUCERS (~20-40%)
- 5.4.3 PRODUCT MANUFACTURING (~40-60%)
- 5.4.4 TESTING & QUALITY ASSURANCE (~60-80%)
- 5.4.5 END USERS (~80-100%)
- 5.5 ECOSYSTEM ANALYSIS
- 5.5.1 PROMINENT COMPANIES
- 5.5.2 PRIVATE AND SMALL ENTERPRISES
- 5.5.3 END USERS
- 5.6 TARIFF AND REGULATORY LANDSCAPE
- 5.7 TRADE DATA
- 5.7.1 IMPORT SCENARIO
- 5.7.2 EXPORT SCENARIO
- 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.8.2 BUYING CRITERIA
- 5.9 USE CASE ANALYSIS
- 5.9.1 USE CASE 1: REAL-TIME PATHOGEN DETECTION AT TORONTO PEARSON INTERNATIONAL AIRPORT
- 5.9.2 USE CASE 2: US-UK STRATEGIC DIALOGUE ON BIOLOGICAL SECURITY
- 5.9.3 USE CASE 3: ENHANCED REMOTE DETECTION OF AEROSOL AND VAPOR THREATS WITH MX908 BEACON
- 5.10 KEY CONFERENCES AND EVENTS, 2025-2026
- 5.11 PRICING ANALYSIS
- 5.11.1 AVERAGE SELLING PRICE OF BIODEFENSE PRODUCTS, BY REGION
- 5.11.2 FACTORS IMPACTING COST IN BIODEFENSE MARKET
- 5.11.3 INDICATIVE PRICING ANALYSIS OF BIODEFENSE TECHNOLOGIES, BY KEY PLAYERS, 2025
- 5.12 INVESTMENT AND FUNDING SCENARIO
- 5.13 IMPACT OF AI/ GENERATIVE AI ON BIODEFENSE MARKET
- 5.13.1 PREDICTIVE BIOSURVEILLANCE
- 5.13.2 NEXT-GENERATION BIOSENSORS
- 5.13.3 RAPID PATHOGEN IDENTIFICATION
- 5.13.4 IMAGE & SIGNAL ANALYSIS
- 5.13.5 SYNTHETIC DATA GENERATION
- 5.14 MACROECONOMIC OUTLOOK
- 5.14.1 INTRODUCTION
- 5.14.2 NORTH AMERICA
- 5.14.3 EUROPE
- 5.14.4 ASIA PACIFIC
- 5.14.5 MIDDLE EAST
- 5.14.6 LATIN AMERICA
- 5.14.7 AFRICA
- 5.15 BUSINESS MODELS
- 5.15.1 BUSINESS MODELS IN BIODEFENSE MARKET
- 5.16 TECHNOLOGY ROADMAP
6 INDUSTRY TRENDS
- 6.1 INTRODUCTION
- 6.2 TECHNOLOGY TRENDS
- 6.2.1 NANOTECHNOLOGY-ENABLED BIOSENSORS
- 6.2.2 DIGITAL HEALTH TOOLS & MOBILE BIOSURVEILLANCE
- 6.2.3 REMOTE SENSING FOR DETECTION AND IDENTIFICATION OF BIOLOGICAL THREATS
- 6.2.4 DIGITAL TWINS & SIMULATION TECHNOLOGY
- 6.3 IMPACT OF MEGATRENDS
- 6.3.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING FOR BIOTHREAT DETECTION
- 6.3.2 BLOCKCHAIN FOR SUPPLY CHAIN AND DATA INTEGRITY
- 6.4 TECHNOLOGY ANALYSIS
- 6.4.1 KEY TECHNOLOGIES
- 6.4.1.1 Real-time aerosol detectors
- 6.4.1.2 Mass spectrometry
- 6.4.2 COMPLEMENTARY TECHNOLOGIES
- 6.4.2.1 Decision support systems
- 6.4.2.2 Geospatial information systems
- 6.4.3 ADJACENT TECHNOLOGIES
- 6.4.3.1 High-throughput screening
- 6.4.3.2 Digital identity and biometric authentication
- 6.5 PATENT ANALYSIS
7 BIODEFENSE MARKET, BY PRODUCT
- 7.1 INTRODUCTION
- 7.2 DETECTION & SURVEILLANCE
- 7.2.1 INCREASING THREAT OF EMERGING INFECTIOUS DISEASES AND BIOTERRORISM TO DRIVE SEGMENTAL GROWTH
- 7.2.2 BIOSENSOR SYSTEMS
- 7.2.3 AI-BASED PLATFORMS
- 7.3 DECONTAMINATION SYSTEMS
- 7.3.1 RISING GOVERNMENT AND DEFENSE SECTOR INVESTMENTS IN BIOSECURITY INFRASTRUCTURE TO DRIVE SEGMENTAL GROWTH
- 7.3.2 DISINFECTION UNITS
- 7.3.3 STERILIZATION DEVICES
- 7.4 OTHERS
- 7.4.1 PURIFICATION UNITS
- 7.4.2 CONTAINMENT & ISOLATION DEVICES
8 BIODEFENSE MARKET, BY TECHNOLOGY
- 8.1 INTRODUCTION
- 8.2 GHZ-BAND WAVE EMISSION FOR AIRBORNE VIRAL INACTIVATION
- 8.2.1 CHEMICAL-FREE AND RAPID DECONTAMINATION FEATURE TO DRIVE GROWTH
- 8.3 UV-BASED TECHNOLOGIES
- 8.3.1 GROWING NEED TO REDUCE SPREAD OF AIRBORNE OR SURFACE-DEPOSITED PATHOGENS IN HIGH-RISK AREAS TO DRIVE GROWTH
- 8.4 MICROWAVE HEATING
- 8.4.1 ABILITY TO QUICKLY DISINFECT CONFINED SPACES OR CRITICAL SURFACES EXPOSED TO AIRBORNE BIOTERROR AGENTS TO DRIVE GROWTH
- 8.5 RADIOFREQUENCY (RF-EMR) HEATING
- 8.5.1 STERILIZATION AND DISINFECTION APPLICATIONS TO DRIVE GROWTH
- 8.6 COLD PLASMA-BASED PATHOGEN INACTIVATION
- 8.6.1 BROAD-SPECTRUM PATHOGEN INACTIVATION TO DRIVE GROWTH
- 8.7 GAMMA RADIATION
- 8.7.1 LONG-RANGE AND HIGH-VOLUME APPLICATION TO DRIVE GROWTH
- 8.8 BIOSENSOR TECHNOLOGIES
- 8.8.1 IMMEDIATE THREAT IDENTIFICATION WITHOUT FULL LABORATORY SUPPORT TO DRIVE GROWTH
- 8.8.1.1 Electrochemical biosensors
- 8.8.1.2 Optical biosensors
- 8.8.1.3 Piezoelectric biosensors
- 8.8.1.4 Thermal biosensors
- 8.8.1.5 Nanomechanical biosensors
- 8.9 AI TECHNOLOGIES
- 8.9.1 ABILITY TO PREDICT OUTBREAKS AND IDENTIFY EMERGING THREATS IN REAL TIME TO DRIVE GROWTH
- 8.9.1.1 Machine learning for outbreak prediction
- 8.9.1.2 AI integration with surveillance networks
- 8.10 OTHERS
9 BIODEFENSE MARKET, BY APPLICATION
- 9.1 INTRODUCTION
- 9.2 MILITARY
- 9.2.1 THREAT OF BIOLOGICAL WARFARE TO DRIVE DEMAND
- 9.3 HOMELAND SECURITY
- 9.3.1 INCREASING NEED FOR DETECTION AND EARLY WARNING BIODEFENSE SYSTEMS TO DRIVE DEMAND
- 9.4 PUBLIC INFRASTRUCTURE
- 9.4.1 HIGH NEED FOR SAFEGUARDING CITIZENS AND ENSURING RESILIENCE IN FACE OF BIOLOGICAL RISKS TO DRIVE DEMAND
- 9.5 HOSPITALS & MEDICAL INSTITUTES
- 9.5.1 GROWING NEED FOR HEALTHCARE SYSTEM RESILIENCE TO DRIVE DEMAND
- 9.6 OTHERS
10 BIODEFENSE MARKET, BY REGION
- 10.1 INTRODUCTION
- 10.2 NORTH AMERICA
- 10.2.1 PESTLE ANALYSIS
- 10.2.2 US
- 10.2.2.1 Rise in global geopolitical tensions due to concerns about bioterrorism and state-sponsored biological programs to drive market
- 10.2.3 CANADA
- 10.2.3.1 Government's focus on enhancing public health infrastructure to drive market
- 10.3 ASIA PACIFIC
- 10.3.1 PESTLE ANALYSIS
- 10.3.2 INDIA
- 10.3.2.1 Growing national security concerns considering strained relations with neighboring countries to drive market
- 10.3.3 AUSTRALIA
- 10.3.3.1 Increasing government initiatives and investments to drive market
- 10.3.4 CHINA
- 10.3.4.1 Focus on strengthening biosecurity and strategic biotechnology development to drive market
- 10.3.5 JAPAN
- 10.3.5.1 Heightened awareness of biological threats to drive market
- 10.3.6 REST OF ASIA PACIFIC
- 10.4 EUROPE
- 10.4.1 PESTLE ANALYSIS
- 10.4.2 GERMANY
- 10.4.2.1 Comprehensive biosecurity programs and institutional collaboration to drive market
- 10.4.3 UK
- 10.4.3.1 Growing focus on biosurveillance to drive market
- 10.4.4 FRANCE
- 10.4.4.1 Increasing government investment in bioproduction infrastructure and public health preparedness to drive market
- 10.4.5 ITALY
- 10.4.5.1 Increasing focus on building biodefense infrastructure to drive market
- 10.4.6 REST OF EUROPE
- 10.5 REST OF THE WORLD (ROW)
- 10.5.1 PESTLE ANALYSIS
- 10.5.2 MIDDLE EAST & AFRICA
- 10.5.2.1 Increasing need for preparedness for emerging biological threats to drive market
- 10.5.3 LATIN AMERICA
- 10.5.3.1 International collaborations to strengthen national biodefense efforts to drive market
11 COMPETITIVE LANDSCAPE
- 11.1 INTRODUCTION
- 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2025
- 11.3 BIODEFENSE MARKET REVENUE ANALYSIS, 2020-2025
- 11.4 BIODEFENSE MARKET SHARE ANALYSIS, 2024
- 11.5 BIODEFENSE MARKET COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 11.5.5.1 Company footprint
- 11.5.5.2 Product footprint
- 11.5.5.3 Technology footprint
- 11.5.5.4 Application footprint
- 11.5.5.5 Region footprint
- 11.6 BIODEFENSE MARKET COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING
- 11.6.5.1 List of startups/SMEs
- 11.6.5.2 Competitive benchmarking of startups/SMEs
- 11.7 BRAND/PRODUCT COMPARISON
- 11.8 COMPANY VALUATION AND FINANCIAL METRICS
- 11.9 COMPETITIVE SCENARIO
- 11.9.1 DEALS
- 11.9.2 OTHER DEVELOPMENTS
12 COMPANY PROFILES
- 12.1 KEY PLAYERS
- 12.1.1 STERIS
- 12.1.1.1 Business overview
- 12.1.1.2 Products offered
- 12.1.1.3 Recent developments
- 12.1.1.4 MnM view
- 12.1.1.4.1 Key strengths
- 12.1.1.4.2 Strategic choices
- 12.1.1.4.3 Weaknesses and competitive threats
- 12.1.2 ASP INTERNATIONAL GMBH
- 12.1.2.1 Business overview
- 12.1.2.2 Products offered
- 12.1.2.3 MnM view
- 12.1.2.3.1 Key strengths
- 12.1.2.3.2 Strategic choices
- 12.1.2.3.3 Weaknesses and competitive threats
- 12.1.3 USHIO INC.
- 12.1.3.1 Business overview
- 12.1.3.2 Products offered
- 12.1.3.3 Recent developments
- 12.1.3.4 MnM view
- 12.1.3.4.1 Key strengths
- 12.1.3.4.2 Strategic choices
- 12.1.3.4.3 Weaknesses and competitive threats
- 12.1.4 SOTERA HEALTH COMPANY
- 12.1.4.1 Business overview
- 12.1.4.2 Products offered
- 12.1.4.3 MnM view
- 12.1.4.3.1 Key strengths
- 12.1.4.3.2 Strategic choices
- 12.1.4.3.3 Weaknesses and competitive threats
- 12.1.5 BIOQUELL, AN ECOLAB SOLUTION
- 12.1.5.1 Business overview
- 12.1.5.2 Products offered
- 12.1.5.3 MnM view
- 12.1.5.3.1 Key strengths
- 12.1.5.3.2 Strategic choices
- 12.1.5.3.3 Weaknesses and competitive threats
- 12.1.6 THERMO FISHER SCIENTIFIC INC.
- 12.1.6.1 Business overview
- 12.1.6.2 Products offered
- 12.1.6.3 Recent developments
- 12.1.7 SMITHS DETECTION GROUP LTD
- 12.1.7.1 Business overview
- 12.1.7.2 Products offered
- 12.1.7.3 Recent developments
- 12.1.8 E4LIFE SRL.
- 12.1.8.1 Business overview
- 12.1.8.2 Products offered
- 12.1.9 SYNEXIS
- 12.1.9.1 Business overview
- 12.1.9.2 Products offered
- 12.1.9.3 Recent developments
- 12.1.10 BLUEDOT INC.
- 12.1.10.1 Business overview
- 12.1.10.2 Products offered
- 12.1.10.3 Recent developments
- 12.1.11 XENEX DISINFECTION SERVICES INC.
- 12.1.11.1 Business overview
- 12.1.11.2 Products offered
- 12.1.11.3 Recent developments
- 12.1.11.3.1 Other developments
- 12.1.12 SKAN AG
- 12.1.12.1 Business overview
- 12.1.12.2 Products offered
- 12.1.12.3 Recent developments
- 12.1.13 MICROSOFT
- 12.1.13.1 Business overview
- 12.1.13.2 Products offered
- 12.1.14 BIO-RAD LABORATORIES, INC.
- 12.1.14.1 Business overview
- 12.1.14.2 Products offered
- 12.1.15 AIRBOSS DEFENSE GROUP, INC.
- 12.1.15.1 Business overview
- 12.1.15.2 Products offered
- 12.1.15.3 Recent developments
- 12.2 OTHER PLAYERS
- 12.2.1 IONISOS
- 12.2.2 AQUISENSE
- 12.2.3 GERMFREE
- 12.2.4 PATHOGENFOCUS
- 12.2.5 UV LIGHT TECHNOLOGY LTD - PART OF DARO GROUP
- 12.2.6 BERTIN TECHNOLOGIES
- 12.2.7 FAR UV TECHNOLOGIES, INC.
- 12.2.8 PURE AQUA, INC.
- 12.2.9 PALANTIR TECHNOLOGIES INC.
- 12.2.10 PUSCHNER MICROWAVE POWER SYSTEMS
13 APPENDIX
- 13.1 DISCUSSION GUIDE
- 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 13.3 CUSTOMIZATION OPTIONS
- 13.4 RELATED REPORTS
- 13.5 COMPANY LONG LIST
- 13.6 AUTHOR DETAILS
